Market closed

Delcath Systems/DCTH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Delcath Systems

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Ticker

DCTH
Trading on

Industry

Health Care Equipment & Supplies

Employees

76

Delcath Systems Metrics

BasicAdvanced
$246M
Market cap
-
P/E ratio
-$2.39
EPS
0.64
Beta
-
Dividend rate
$246M
0.64
$11.75
$2.25
323K
2.555
1.925
4.945
27.914
-54.37%
-81.99%
-478.59%
17.37
58.43
58.43
-6.548
350.44%
-23.02%
84.28%
-18.94%

What the Analysts think about Delcath Systems

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Delcath Systems stock.

Delcath Systems Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Delcath Systems Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy DCTH

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Delcath Systems stock?

Delcath Systems (DCTH) has a market cap of $246M as of October 06, 2024.

What is the P/E ratio for Delcath Systems stock?

The price to earnings (P/E) ratio for Delcath Systems (DCTH) stock is 0 as of October 06, 2024.

Does Delcath Systems stock pay dividends?

No, Delcath Systems (DCTH) stock does not pay dividends to its shareholders as of October 06, 2024.

When is the next Delcath Systems dividend payment date?

Delcath Systems (DCTH) stock does not pay dividends to its shareholders.

What is the beta indicator for Delcath Systems?

Delcath Systems (DCTH) has a beta rating of 0.64. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.